The glutamate metabotropic receptor 3 (GRM3) gene has been widely investigated since it modulates signaling through NMDA receptors which are a relevant contributor to the cognitive and negative symptoms of schizophrenia (Maj et al., 2016). Here, GRM3 is linked to schizophrenia.